Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7566458 Influenza hemagglutinin and neuraminidase variants

Patent 7566458 was granted and assigned to MedImmune on July, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

MedImmune

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7566458

Date of Patent

July 28, 2009

Patent Application Number

10870690

Date Filed

June 16, 2004

Patent Citations Received

‌

US Patent 12024552 Ha binding agents

‌

US Patent 11865173 Influenza virus hemagglutinin proteins and uses thereof

‌

US Patent 12122807 Influenza virus replication for vaccine development

‌

US Patent 12076387 Vaccines comprising mutant attenuated influenza viruses

‌

US Patent 11802273 Mutations that confer genetic stability to additional genes in influenza viruses

‌

US Patent 11851648 Humanized cell line

Patent Primary Examiner

‌

Bruce Campell

Patent abstract

Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7566458 Influenza hemagglutinin and neuraminidase variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API